The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 07, 2015
Filed:
Apr. 21, 2009
Hee Gu Lee, Daejeon, KR;
Eun Young Song, Daejeon, KR;
Min Ah Kang, Gumi-si, KR;
Jong Tae Kim, Daejeon, KR;
Jae Wha Kim, Daejeon, KR;
Young IL Yeom, Daejeon, KR;
Seon Young Kim, Daejeon, KR;
Kyung Chan Park, Daejeon, KR;
Hee Gu Lee, Daejeon, KR;
Eun Young Song, Daejeon, KR;
Min Ah Kang, Gumi-si, KR;
Jong Tae Kim, Daejeon, KR;
Jae Wha Kim, Daejeon, KR;
Young Il Yeom, Daejeon, KR;
Seon Young Kim, Daejeon, KR;
Kyung Chan Park, Daejeon, KR;
Korea Research Institute of Bioscience and Biotechnology, Daejeon, KR;
Abstract
The present invention relates to a biomarker for gastric cancer, CST1 (cysteine proteinase inhibitor, type 2 family), DCC1 (Defective in sister chromatid cohesion homolog 1), IFITM1 (interferon induced transmembrane protein 1) or MELK (maternal embryonic leucine zipper kinase). More particularly, the present invention relates to a diagnostic composition for gastric cancer comprising an agent measuring the expression level of CST1, DCC1, IFITM1 or MELK, a kit comprising the composition, a method for detecting the marker, and a method for screening a therapeutic agent for gastric cancer using the marker.